Application of "Precision Medicine" Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient

Clin Infect Dis. 2017 Aug 15;65(4):701-702. doi: 10.1093/cid/cix387.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Antibiotic Prophylaxis
  • Carbapenems / therapeutic use
  • Drug Resistance, Multiple, Bacterial* / genetics
  • Ertapenem / therapeutic use
  • Female
  • Fosfomycin / therapeutic use
  • Humans
  • Intestines / transplantation*
  • Kidney Transplantation*
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / genetics*
  • Meropenem / therapeutic use
  • Postoperative Complications / drug therapy
  • Postoperative Complications / microbiology
  • Precision Medicine*

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Fosfomycin
  • Meropenem
  • Ertapenem